CRISPR Therapeutics AG CRSP
NASDAQ CRSP
$45.48 +0.33 (+0.73%)
As of: Nov 11, 2026 · 11:53 AM EST

CRISPR Therapeutics AG (CRSP) Net Equity Issued and Repurchased (2016 - 2026)

Updated

CRISPR Therapeutics AG's Net Equity Issued and Repurchased came in at $4.45 million for Q3 2026, down 98.5% from $296.77 million a year earlier and down 46.4% from the prior quarter.

Analysis

CRISPR Therapeutics AG (CRSP) Net Equity Issued and Repurchased (2016 - 2026) Analysis & Trends

Over the trailing twelve months to Sep 30, 2026, CRISPR Therapeutics AG reported Net Equity Issued and Repurchased of $134.61 million, down 58.8% year-over-year; for FY2025, it came in at $426.03 million, up 28.3% from FY2024.

  • Net Equity Issued and Repurchased has increased in each of the last three years, though with a five-year compound annual growth rate of -16.0% (FY2020 to FY2025).
  • Going back by year, Net Equity Issued and Repurchased was $331.98 million in FY2024 (+429.8%), $62.66 million in FY2023 (+62.4%), $38.59 million in FY2022 (-84.6%) and $250.95 million in FY2021 (-75.3%).
  • The Q3 2026 figure represents the lowest quarterly Net Equity Issued and Repurchased since Q2 2025.
  • Year-over-year, Net Equity Issued and Repurchased increased in two of the last six quarters, with growth averaging 92.9%.
  • The fastest year-over-year change in Net Equity Issued and Repurchased over five years came in Q4 2025 (growth of 589.8%), and the weakest in Q3 2026 (a decline of 98.5%).
  • Business Quant data shows CRSP's Net Equity Issued and Repurchased at $8.3 million (Q2 2026), $5.44 million (Q1 2026) and $116.41 million (Q4 2025) in the three quarters before Q3 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -377.00 Mn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -966.00 Mn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -5.00 Mn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -406.00 Mn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 4.00 Mn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -283.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 CRISPR Therapeutics AG 4.37 Bn -4.68 Bn - 4.45 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 4.45 Mn
Jun 30, 2026 8.30 Mn
Mar 31, 2026 5.44 Mn
Dec 31, 2025 116.41 Mn
Sep 30, 2025 296.77 Mn
Jun 30, 2025 2.26 Mn
Mar 31, 2025 10.59 Mn
Dec 31, 2024 16.88 Mn
Sep 30, 2024 9.64 Mn
Jun 30, 2024 -466,000.00
Mar 31, 2024 305.93 Mn
Dec 31, 2023 38.94 Mn
Sep 30, 2023 1.56 Mn
Jun 30, 2023 16.77 Mn
Mar 31, 2023 5.40 Mn
Dec 31, 2022 2.48 Mn
Sep 30, 2022 15.11 Mn
Jun 30, 2022 10.35 Mn
Mar 31, 2022 10.65 Mn
Dec 31, 2021 6.30 Mn
API Access

CRISPR Therapeutics AG Net Equity Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=CRSP&period=max&api_key=YOUR_API_KEY